TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. (7th January 2015)
- Record Type:
- Journal Article
- Title:
- TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. (7th January 2015)
- Main Title:
- TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia
- Authors:
- Martin‐Rodriguez, Susana
Caballo, Carolina
Gutierrez, Gabriela
Vera, Manel
Cruzado, Josep M.
Cases, Aleix
Escolar, Gines
Diaz‐Ricart, Maribel - Abstract:
- <abstract abstract-type="main" id="eci12392-abs-0001"> <title>Abstract</title> <sec id="eci12392-sec-0001" sec-type="section"> <title>Background</title> <p>The increased cardiovascular risk present in chronic kidney disease (CKD) is related to the development of endothelial dysfunction, whose mechanisms are still unclear. Accumulation of toxins and proinflammatory cytokines may constitute danger‐associated molecular patterns (DAMP) to which endothelial cells are continuously exposed. Potential involvement of mechanisms recognizing DAMP, such as TLR and inflammasomes, has been explored.</p> </sec> <sec id="eci12392-sec-0002" sec-type="section"> <title>Materials and methods</title> <p>Endothelial cells in culture were exposed to sera samples collected from patients with CKD: (i) stages 4–5 not on dialysis (PreD), (ii) on maintenance haemodialysis (HD) and (iii) peritoneal dialysis (PD). Changes in TLR4 and ICAM‐1 expression, reactive oxygen species (ROS) production and TLR4 signalling were explored. Assembly of NALP3 inflammasome components was also investigated.</p> </sec> <sec id="eci12392-sec-0003" sec-type="section"> <title>Results</title> <p>TLR4 was expressed at the cell surface and increased significantly in response to PreD, HD and PD sera, paralleling with the activation of the cell stress protein Akt and the inflammation‐related transcription factor NFκB, with elevated surface ICAM‐1 expression and ROS production. TLR4 blockade partially decreased these effects.<abstract abstract-type="main" id="eci12392-abs-0001"> <title>Abstract</title> <sec id="eci12392-sec-0001" sec-type="section"> <title>Background</title> <p>The increased cardiovascular risk present in chronic kidney disease (CKD) is related to the development of endothelial dysfunction, whose mechanisms are still unclear. Accumulation of toxins and proinflammatory cytokines may constitute danger‐associated molecular patterns (DAMP) to which endothelial cells are continuously exposed. Potential involvement of mechanisms recognizing DAMP, such as TLR and inflammasomes, has been explored.</p> </sec> <sec id="eci12392-sec-0002" sec-type="section"> <title>Materials and methods</title> <p>Endothelial cells in culture were exposed to sera samples collected from patients with CKD: (i) stages 4–5 not on dialysis (PreD), (ii) on maintenance haemodialysis (HD) and (iii) peritoneal dialysis (PD). Changes in TLR4 and ICAM‐1 expression, reactive oxygen species (ROS) production and TLR4 signalling were explored. Assembly of NALP3 inflammasome components was also investigated.</p> </sec> <sec id="eci12392-sec-0003" sec-type="section"> <title>Results</title> <p>TLR4 was expressed at the cell surface and increased significantly in response to PreD, HD and PD sera, paralleling with the activation of the cell stress protein Akt and the inflammation‐related transcription factor NFκB, with elevated surface ICAM‐1 expression and ROS production. TLR4 blockade partially decreased these effects. Exposure of cells to uraemic sera induced assembly of NALP3 components, with caspase‐1 activation, especially in response to HD and PD sera.</p> </sec> <sec id="eci12392-sec-0004" sec-type="section"> <title>Conclusions</title> <p>TLR4 and NALP3 inflammasomes, crucial elements of innate immunity, contribute to the development and perpetuation of endothelial dysfunction in response to the uraemic toxicity. These mechanisms constitute potential therapeutic targets to improve endothelial dysfunction and to reduce the increased cardiovascular risk in CKD.</p> </sec> </abstract> … (more)
- Is Part Of:
- European journal of clinical investigation. Volume 45:Number 2(2015:Feb.)
- Journal:
- European journal of clinical investigation
- Issue:
- Volume 45:Number 2(2015:Feb.)
- Issue Display:
- Volume 45, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 45
- Issue:
- 2
- Issue Sort Value:
- 2015-0045-0002-0000
- Page Start:
- 160
- Page End:
- 169
- Publication Date:
- 2015-01-07
- Subjects:
- Pathology -- Periodicals
Medical research -- Periodicals
616.075 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2362 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/eci.12392 ↗
- Languages:
- English
- ISSNs:
- 0014-2972
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.727100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3541.xml